In this case, we note that YKL-40 and both forms of tau rose toward levels similar to other manifest HD subjects at the second sample, whereas baseline NFL was already in the range of the manifest group, in line with the hypothesis of NFL as a suitable HD biomarker, that rises long before motor onset [11, 14]. The gene discussed is MAPT; the disease is Huntington disease.